Lars Lind

93.5k citations
681 papers · 29.2k · 5 hit papers · h-index 87

Impact in

  • Nephrology top 0.1%
    • Parathyroid Disorders and Treatments
    • Blood Pressure and Hypertension Studies
    • Cardiovascular Health and Disease Prevention
    • Heart Rate Variability and Autonomic Control
    • Cardiovascular Function and Risk Factors

Papers in

Lars Lind

670 papers receiving 28.4k citations

Lars Lind's Hit Papers

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study 2018 · 287 citations
2870+6+12Years since publication200400600

Peers

Lars Lind
Comparison fields: 5 of 193
  • Nephrology 3.0k
  • Cardiology and Cardiovascular Medicine 9.1k
  • Health, Toxicology and Mutagenesis 3.7k
  • Endocrinology, Diabetes and Metabolism 3.9k
  • Physiology 4.9k
Replace Barbara V. Howard with:
Barbara V. Howard United States
Eliseo Güallar United States
Nancy R. Cook United States
David S. Siscovick United States
Nosratola D. Vaziri United States
A. Richey Sharrett United States
Hiroyasu Iso Japan
Kiang Liu United States
Gregory L. Burke United States
Gerardo Heiss United States
Lars Lind relative to Barbara V. Howard United States Barbara V. Howard's profile →
Citations per field
00.5×3.1×
Barbara V. Howard · 1×
Citations per year

Countries citing papers authored by Lars Lind

Since Specialization
Citations

This map shows the geographic impact of Lars Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Lind more than expected).

Fields of papers citing papers by Lars Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Lind. The network helps show where Lars Lind may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Lind Line = papers co-authored together Lars Lind links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 681 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study
Hit paper breakdown →
2007660
2
Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
Hit paper breakdown →
2009484
3 2005446
4
Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data
Hit paper breakdown →
2012407
5 2005359
6 2009339
7 2005314
8 2006313
9 2009305
10
The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer's disease
Hit paper breakdown →
2014297
11
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
Hit paper breakdown →
2018287
12 2014287
13 2009275
14 2007261
15 2013257
16 2003253
17 2011251
18 2003247
19 2001246
20 1995241

About Lars Lind

Lars Lind is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Endocrinology, Diabetes and Metabolism, Molecular Biology and Health, Toxicology and Mutagenesis, having authored 681 papers that have together received 29.2k indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (124 papers), Blood Pressure and Hypertension Studies (112 papers), Heart Rate Variability and Autonomic Control (56 papers), Effects and risks of endocrine disrupting chemicals (53 papers), Cardiovascular Function and Risk Factors (52 papers), Toxic Organic Pollutants Impact (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers) and Cerebrovascular and Carotid Artery Diseases (45 papers). The work is most often cited by research in Nephrology (3.0k citations), Cardiology and Cardiovascular Medicine (9.1k citations), Health, Toxicology and Mutagenesis (3.7k citations), Endocrinology, Diabetes and Metabolism (3.9k citations) and Physiology (4.9k citations). Lars Lind has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Johan Sundström, Johan Ärnlöv, Peter Lind, Hans Lithell, Erik Ingelsson, Anders Larsson, Samira Salihović, Björn Zethelius, Sver­ker Ljunghall and Bert van Bavel. Their work appears in journals such as Atherosclerosis, Journal of Hypertension, Journal of Internal Medicine, Clinical Physiology and Functional Imaging and Environment International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact